Mercer Global Advisors
VERA icon

Mercer Global Advisors’s Vera Therapeutics VERA Stock Holding History

Mercer Global Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.9K Buy
+1,815
New +$67.6K ﹤0.01% 4025

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Mercer Global Advisors's VERA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Vera Therapeutics (VERA) in Q2 2026: 1,815 shares worth $77.9K. The stake represents ﹤0.01% of the portfolio and ranks #4025 among its holdings.

202 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Mercer Global Advisors held 1,815 shares of Vera Therapeutics worth $77.9K as of Q2 2026.
  • Vera Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4025 holding.
  • 202 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.